Multispecific Antibodies Offer Flexibility in Drug Development
As outlined in the first part of this article scanning the rapidly evolving technology landscape of bispecific and multispecific antibodies, interest in them has been renewed big time because various manufacturing, stability and safety issues have been addressed. The field now encompasses a multitude of approaches for creating antibodies against a variety of targets and the number of companies entering this space is surging.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST